Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.0700-0.0700 (-3.27%)
At close: 04:00PM EST
2.0800 +0.01 (+0.48%)
After hours: 05:48PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 12/12/2021
Current
9/30/2021
Market Cap (intraday)
90.39M113.96M
Enterprise Value
50.28M141.01M
Trailing P/E
N/AN/A
Forward P/E
N/AN/A
PEG Ratio (5 yr expected)
N/AN/A
Price/Sales (ttm)
22.0526.65
Price/Book (mrq)
1.67N/A
Enterprise Value/Revenue
12.26N/A
Enterprise Value/EBITDA
-6.63-35.54

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-65.87%
S&P500 52-Week Change 318.83%
52 Week High 37.7750
52 Week Low 32.0100
50-Day Moving Average 32.6141
200-Day Moving Average 33.4200

Share Statistics

Avg Vol (3 month) 33.05M
Avg Vol (10 day) 368.66k
Shares Outstanding 535.73M
Implied Shares Outstanding 6N/A
Float 812.34M
% Held by Insiders 175.15%
% Held by Institutions 10.68%
Shares Short (Dec 30, 2021) 4123.27k
Short Ratio (Dec 30, 2021) 40.9
Short % of Float (Dec 30, 2021) 40.71%
Short % of Shares Outstanding (Dec 30, 2021) 40.34%
Shares Short (prior month Nov 29, 2021) 493.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin -186.07%
Operating Margin (ttm)-199.87%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)4.1M
Revenue Per Share (ttm)0.37
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)4.1M
EBITDA -7.58M
Net Income Avi to Common (ttm)-8.06M
Diluted EPS (ttm)-0.7310
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.11M
Total Cash Per Share (mrq)1.12
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)18.19
Book Value Per Share (mrq)1.51

Cash Flow Statement

Operating Cash Flow (ttm)-11.14M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement